Caligan Partners LP - 19 Nov 2025 SCHEDULE 13D/A Report for Anika Therapeutics, Inc. Common Stock, par value $0.01 per share (ANIK)

Filing Manager
Caligan Partners LP
Reporting Manager
Caligan Partners LP
Security
Anika Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol
ANIK
Shares outstanding
14,423,417 shares
Disclosed Ownership
1,435,130 shares
Ownership
10%
Form type
SCHEDULE 13D/A
Filing time
21 Nov 2025, 09:21:42 UTC
Date of event
19 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Caligan Partners LP 10% 1,435,130 0 1,435,130 /s/ David Johnson David Johnson, Managing Partner 0001727492
David Johnson 10% 1,435,130 0 1,435,130 /s/ David Johnson David Johnson, individually 0001785557